FITC Anti-Human CD37 Antibody [IPO-24] (AGEL1017)

FITC Anti-Human CD37 Antibody [IPO-24]

The Human CD37 Monoclonal Antibody FITC-conjugated (IPO-24) is a specialized tool for researchers studying CD37, a protein found on the surface of human cells that plays a key role in immune system function. This monoclonal antibody, conjugated with FITC for fluorescence detection, is produced for use in various immunological research applications.CD37 is a transmembrane glycoprotein known to be involved in B-cell signaling and activation, making it a vital target for investigations in immunology and cancer biology. By specifically binding to CD37, this antibody allows for precise identification and analysis of CD37-expressing cells in diverse experimental settings.

Its FITC conjugation enhances visualization and tracking of CD37-positive cells, enabling detailed studies on their behavior and function.Researchers exploring immune cell interactions, signal transduction pathways, and disease mechanisms rely on tools like the Human CD37 Monoclonal Antibody FITC-conjugated (IPO-24) to advance their understanding of immune responses and develop potential therapeutic strategies. With its proven specificity and versatility, this antibody is a valuable asset for uncovering the intricacies of CD37 biology and its implications in health and disease.

Isotype:	Mouse IgG2b, κ
Isotype Control:	FITC Mouse IgG2b, κ Isotype Control[MPC-11]
Form:	Liquid
Conjugation:	FITC
Recommended Use:	Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
Spectrum: